What is the treatment for a fungal infection involving the perionyxium (nail fold)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Fungal Infection of the Nail Fold (Perionychium)

For fungal infections involving the nail fold (perionychium), topical antifungal therapy is the first-line treatment, with amorolfine 5% nail lacquer or ciclopirox 8% nail lacquer being the most effective options. 1

Diagnosis Considerations

Before initiating treatment, it's important to identify the causative organism:

  • Candida paronychia is the most common fungal infection of the nail fold
  • Symptoms include swollen, erythematous, and painful periungual skin
  • A gap often develops between the nail fold and nail plate
  • Nail plate involvement typically starts proximally with white, green, or black marks
  • Unlike dermatophyte infections, pressure on the nail is painful 1

Treatment Algorithm

First-line Treatment:

  1. Topical antifungal therapy:

    • Amorolfine 5% nail lacquer: Apply once or twice weekly for 6-12 months
    • Ciclopirox 8% nail lacquer: Apply once daily for up to 48 weeks 1, 2
    • Remove as much diseased nail as possible by gentle filing before application
  2. Adjunctive measures:

    • Keep nails short
    • Avoid sharing nail clippers
    • Disinfect footwear
    • Apply antifungal powders inside shoes 3

For Candida Paronychia (most common in nail fold infections):

  1. Topical therapy as above
  2. If unresponsive to topical therapy, consider:
    • Itraconazole: Particularly effective for Candida infections with 92% cure rate using pulse therapy (400 mg daily for 1 week per month) 3
    • Fluconazole: 150-450 mg once weekly for 3 months (fingernails) or 6 months (toenails) 3, 4

For Severe or Resistant Cases:

  1. Terbinafine: 250 mg daily for 6 weeks (fingernails) or 12 weeks (toenails)

    • Most effective for dermatophyte infections with 80-90% cure rates for fingernails and 70-80% for toenails 3
    • Fungicidal action provides better outcomes than fungistatic agents 5
  2. Itraconazole: Alternative when terbinafine is contraindicated

    • 200 mg daily for 12 weeks (continuous therapy) or
    • 400 mg daily for 1 week per month (pulse therapy) 3

Special Considerations

  • Monitoring: For oral antifungals, baseline liver function tests and complete blood count are recommended, particularly in patients with history of hepatotoxicity 3

  • Treatment duration: Follow-up is recommended for at least 48 weeks from treatment initiation, with re-evaluation 3-6 months after starting treatment 3

  • Bacterial superinfection: Common in Candida paronychia and may require additional antimicrobial treatment 1

  • Treatment failure: May be due to poor compliance, poor drug absorption, immunosuppression, or resistance. Consider:

    • Partial nail removal
    • Alternative antifungal drug
    • Complete nail removal in combination with further antifungal therapy 3

Efficacy Considerations

  • Topical treatments show variable success rates (20-70%) depending on the extent of infection 1
  • Systemic therapy is almost always more successful than topical treatment but should be reserved for cases unresponsive to topical therapy 1
  • Mycological cure rates are typically about 30% better than clinical cure rates 1
  • Fungicidal drugs (terbinafine, naftifine, butenafine) are generally preferred over fungistatic drugs (azoles) for dermatophyte infections 6
  • Azole drugs are often preferred for Candida infections 6

By following this treatment approach, most fungal infections of the nail fold can be effectively managed, improving patient outcomes and quality of life.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Onychomycosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Topical therapy for fungal infections.

American journal of clinical dermatology, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.